AFP via Getty
- Global stocks rose on Tuesday as investor sentiment was propped up by a relaxation in coronavirus lockdowns across the world and on news of a new vaccine for the virus.
- US futures point to gains of more than 2% as traders return to work after the long Memorial Day weekend, while major indexes in Europe and Asia also bounced on the day.
- The World Health Organization has temporarily halted trials for hydroxychloroquine amid safety concerns.
- US-China tensions continue to escalate after White House national security adviser attacked the world's second-largest economy for engaging in "espionage" to develop vaccine technology.
- Novavax said it is launching its first human clinical trials of a coronavirus vaccine.
- Visit Business Insider's homepage for more stories.
Global stocks marched higher Tuesday as coronavirus lockdowns continue to be eased around the world, and major economies show tentative signs of recovery, while investors shrug off mounting tensions between the US and China.
Futures for the S&P 500 increased as much as 2.2% during the European morning, while in Asian trade Hong Kong's Hang Seng rose 1.8%, and the pan-European Stoxx 50 rose 0.8%.
See the rest of the story at Business Insider
NOW WATCH: Why thoroughbred horse semen is the world's most expensive liquid
See Also:
- Multiple readings of the stock market's future are near their worst levels ever. UBS says that's set up a 'significant recovery' — and lays out a 2-part playbook to profit from it.
- Americans fell behind on nearly 18 million credit-card and auto-loan payments last month
- US weekly jobless claims hit 2.4 million, bringing the 9-week total to nearly 39 million
SEE ALSO: Trump's senior economic adviser referred to Americans returning to work as 'human capital stock'
from Business Insider https://ift.tt/2X388Vm
No comments:
Post a Comment